Personal tools
You are here: Home Knowledge Base Psychiatric Drug Industry US Congress Investigates Psychiatric Drug Industry Sunday New York Times on Congressional investigation of Harvard psychiatrist
Navigation
 
Document Actions

Sunday New York Times on Congressional investigation of Harvard psychiatrist

Up one level

US Senator Charles E. Grassley helped investigate corruption by the psychiatric drug industry. His investigation revealed that Harvard psychiatrist Dr. Joseph Biederman had illegally covered up much of more than a million dollars he had received from the psychiatric drug industry. Dr. Biederman is credited with helping to increase the number of young people diagnosed as "bipolar" many-fold.

Researchers Fail to Reveal Full Drug Pay by David W. Oaks — last modified 2008-06-09 19:04
The Sunday New York Times (8 June 2008) reports about a world-famous Harvard psychiatrist who is considered a catalyst for the enormous increase in psychiatric drugging of kids. Times claims that US Congressional investigators discovered Harvard's Dr. Joseph Biederman did not disclose to Harvard authorities, as required by law, much of the more than a million dollars he received from psychiatric drug companies. Says NY Times, "his work helped to fuel a controversial 40-fold increase from 1994 to 2003 in the diagnosis of pediatric bipolar disorder." Below article find MindFreedom commentary, follow-up by Wall Street Journal and Bloomberg news.
Sen. Charles E. Grassley helped investigate psychiatric drug company corruption. by David W. Oaks — last modified 2008-06-07 22:41
NY Times caption: Senator Charles E. Grassley pushed three experts in child psychiatry at Harvard to expose their income from consulting fees. Photo credit: J. Scott Applewhite/Associated Press
Dr. Joseph Biederman covered up drug money, says Congress by David W. Oaks — last modified 2008-06-07 22:42
NY Times caption: 'Dr. Joseph Biederman belatedly reported at least $1.6 million in consulting fees."

We are MFI



Jim Gottstein of PsychRights

Jim Gottstein is a psychiatric survivor who is also a Harvard-trained attorney, and founder of MindFreedom Sponsor Group PsychRights. Jim blew the whistle on Eli Lilly by releasing their secret documents about the psychiatric drug Zyprexa to The New York Times. Jim is also president of National Association of Rights Protection and Advocacy (NARPA) a founding Sponsor Group of MFI.
 

Powered by Plone, the Open Source Content Management System site by netCorps

This site conforms to the following standards: